A study to investigate the influence of methylphenidate and atomoxetine in developing risk of depression in patients with Attention-deficit hyperactivity disorder verses controls that do not have ADHD
Latest Information Update: 20 Jul 2016
At a glance
- Drugs Atomoxetine (Primary) ; Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Adverse reactions
- 20 Jul 2016 New trial record